Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Maxigesic vs standard analgesia after radical gastrectomy
KCT0012157Phase 4Not yet recruiting
- Sponsor
- Kyongbo Pharmaceutical Co., Ltd
- Start
- Jul 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of acetaminophen + ibuprofen in gastric cancer (GC) (2 arms), sponsored by Kyongbo Pharmaceutical Co., Ltd. Planned start Jul 2026; status: not yet recruiting.
02
Drugs
acetaminophen + ibuprofen
03
Conditions
gastric cancer (GC)
Beyond the preview
Go deeper on KCT0012157.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on KCT0012157.